| Revision as of 21:15, 12 March 2009 editJfdwolff (talk | contribs)Administrators81,547 edits →Metformin← Previous edit |
Revision as of 21:49, 12 March 2009 edit undoNutriveg (talk | contribs)3,676 edits Use the article talk pageNext edit → |
| Line 73: |
Line 73: |
|
:Zineb is not listed in list of the examined substances, I think they missed it.--] (]) 11:52, 15 January 2009 (UTC) |
|
:Zineb is not listed in list of the examined substances, I think they missed it.--] (]) 11:52, 15 January 2009 (UTC) |
|
:Thank you. Perhaps Zineb was banned previously- if it hasn't been it should be examined - must try to find anything about it. I must get round to adding something on dithiocarbamate health issues- compounds containing them have been used in large quantities worldwide.--] (]) 12:02, 15 January 2009 (UTC) |
|
:Thank you. Perhaps Zineb was banned previously- if it hasn't been it should be examined - must try to find anything about it. I must get round to adding something on dithiocarbamate health issues- compounds containing them have been used in large quantities worldwide.--] (]) 12:02, 15 January 2009 (UTC) |
|
|
|
|
== Metformin == |
|
|
|
|
|
When I removed your addition to ] I took the time to leave an ]. Please be good enough never to use ] without an explanation, either in an edit summary or on the article's talkpage. |
|
|
|
|
|
In articles such as metformin, it would be a bad idea to include material from ''in vitro'' studies or animal models unless they have immense relevance to the subject. There is no epidemiological data suggesting increased risk of AD in metformin use, and you misinterpreted the study in the sense that only the cellular changes of AD were found rather than any symptoms of memory loss etc. It is exactly this kind of stuff that gets grossly misreported in the lay press, and Misplaced Pages should not make the same mistakes. Please leave a note on ] if you think I have misjudged this, but under no circumstance reinsert the content in quesiton without further discussion. Thank you. ] | ] 16:35, 10 March 2009 (UTC) |
|
|
|
|
|
:I note that you have been warned a number of times about edit summaries. ] | ] 16:37, 10 March 2009 (UTC) |
|
|
|
|
|
:You could have had the courtesy of discussing the issue on ] first rather than diving in and simply readding your content in a slightly altered form. Please respond to a more detailed message on that talkpage. ] | ] 23:42, 10 March 2009 (UTC) |
|
|
|
|
|
Could I ask you again not to reinsert your content until you have found some common ground with your fellow editors on ]? ] | ] 21:15, 12 March 2009 (UTC) |
|
Again, please do not remove large sections of articles without an edit summary and/or note on the talk page. Providing such will ensure that your edits are not perceived as accidents or vandalism. Also, when creating any article, including spin offs, it is important to follow the Misplaced Pages:Manual of Style. In this case Misplaced Pages:Layout and Misplaced Pages:Footnotes are of particular importance. I've fixed the most obvious migration errors, but I suggest that you familiarize yourself with the above pages. --DO11.10 (talk) 21:44, 26 December 2008 (UTC)
I see you added the latest banning orders fron EU. Looking at the refs you supplied it does not mention Zineb but does mention maneb and mancozeb, which seems strange to me as the active ingredient is generally agreed to be the dithiocarbamate ligand, which is present in all three. Am I missing something here or have the legislators? --Axiosaurus (talk) 10:38, 15 January 2009 (UTC)
